Estamos no ar no ! Saiba mais
170,18 USD
-4,95
2,83%
No fechamento Atualizado 16 de out. 16:00 EDT
Pré-mercado
Após o fechamento do mercado
170,18
0,00
0%
1 dia
-2,83%
5 dias
3,05%
1 mês
-2,16%
3 meses
0,11%
6 meses
47,24%
No acumulado do ano
-9,8%
1 ano
-9,7%
5 anos
-38,47%
10 anos
120,16%
 

Sobre: Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Funcionários: 40.100

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 31,3%
Neutro 56,3%
Negativo 12,5%
Neutro
Business Wire
há 8 dias
ICON Schedules Third Quarter 2026 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON Schedules Third Quarter 2026 Earnings Conference Call.
ICON Schedules Third Quarter 2026 Earnings Conference Call
Positivo
Zacks Investment Research
mês passado
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Positivo
Seeking Alpha
há 2 meses
Oakmark Concentrated Strategy Q2 2026 Performance Review
The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.
Oakmark Concentrated Strategy Q2 2026 Performance Review
Neutro
Zacks Investment Research
há 2 meses
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Positivo
Zacks Investment Research
há 2 meses
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
Neutro
Business Wire
há 2 meses
ICON Announces Private Offering of Notes
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.
ICON Announces Private Offering of Notes
Neutro
Business Wire
há 2 meses
ICON Announces Results of Annual General Meeting
DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.
ICON Announces Results of Annual General Meeting
Neutro
Seeking Alpha
há 2 meses
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
Negativo
MarketBeat
há 2 meses
Icon Q2 Earnings Call Highlights
Icon NASDAQ: ICLR reported second-quarter 2026 revenue growth and strong bookings as higher pass-through activity supported the top line, while the company continued to manage business-mix pressures affecting reported margins.
Icon Q2 Earnings Call Highlights
Negativo
Zacks Investment Research
há 2 meses
Icon PLC (ICLR) Lags Q2 Earnings Estimates
Icon PLC (ICLR) came out with quarterly earnings of $2.56 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $3.26 per share a year ago.
Icon PLC (ICLR) Lags Q2 Earnings Estimates
Gráficos de preços implementados com Lightweight Charts™